Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2019 03:30 ET | Source: Biofrontera AG

All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares

The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbHThe Management Board intends to help Maruho Deutschland GmbH to successfully complete its...
June 12, 2019 10:58 ET | Source: Biofrontera AG

Biofrontera to Present at Two Upcoming Investor Conferences

Leverkusen, Germany, June 12, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
June 04, 2019 10:00 ET | Source: Biofrontera AG

Biofrontera nominates new candidate for the Supervisory Board

Leverkusen, Germany, June 04, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
May 29, 2019 03:11 ET | Source: Biofrontera AG

Biofrontera Reports First Quarter 2019 Financial Results

Leverkusen, Germany, May 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
May 16, 2019 04:30 ET | Source: Biofrontera AG

Biofrontera Announces Conference Call on May 29, 2019 to Discuss First Quarter 2019 Financial Results

Leverkusen, Germany, May 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
April 29, 2019 02:00 ET | Source: Biofrontera AG

Biofrontera Reports Full Year 2018 Financial Results

Leverkusen, Germany, April 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
April 26, 2019 09:20 ET | Source: Biofrontera AG

Biofrontera AG to hold extraordinary shareholders’ meeting on 15 May 2019

Leverkusen, Germany, April 26, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced in...
April 16, 2019 07:30 ET | Source: Biofrontera AG

Biofrontera reports further positive results from the phase III trial with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck

Leverkusen, Germany, April 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
April 16, 2019 05:30 ET | Source: Biofrontera AG

Biofrontera Announces Conference Call on April 29, 2019 to Discuss 2018 Financial Results

Leverkusen, Germany, April 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
April 15, 2019 06:15 ET | Source: Biofrontera AG

Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019

Leverkusen, Germany, April 15, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...